Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Pfizer, inc. save search
Astellas' and Pfizer's XTANDI® (enzalutamide) Reduced Risk of Death by 34% in Men with Metastatic Hormone-Sensitive Prostate Cancer in Phase 3 ARCHES Study
Published: 2021-09-17 (Crawled : 22:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
| Email alert
Add to watchlist
risk prostate cancer cancer phase 3 hormone
UK’s MHRA Grants Marketing Authorisation for Pfizer’s CIBINQO® (abrocitinib) for Adults and Adolescents With Moderate to Severe Atopic Dermatitis
Published: 2021-09-09 (Crawled : 12:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.09%
H: 0.53%
C: -0.95%
dermatitis atopic dermatitis granted grant
Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for MYFEMBREE® for the Management of Moderate to Severe Pain Associated With Endometriosis
Published: 2021-09-09 (Crawled : 11:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.09%
H: 0.53%
C: -0.95%
MYOV | $26.98 -0.04% 0.0% 0
|
Health Technology
|
| O: -0.54%
H: 1.56%
C: -2.22%
new drug fda fda acceptance drug
Global Cancer Diagnostics Market to Reach $213.7 Billion by 2026
Published: 2021-09-07 (Crawled : 16:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.23%
H: 1.09%
C: -0.51%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.84%
H: 0.1%
C: -0.78%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.41%
H: 0.7%
C: -1.62%
CTS S | $43.43 0.77% 0.0% 120K
|
Electronic Technology
|
| O: -0.09%
H: 0.09%
C: -1.28%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: 0.0%
H: 0.39%
C: 0.0%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: 1.12%
H: 0.05%
C: -0.87%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.53%
H: 0.28%
C: 0.21%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -0.27%
H: 0.03%
C: -0.87%
HOLX | $75.37 0.36% 0.36% 1.3M
|
Health Technology
|
| O: -0.54%
H: 0.29%
C: -0.04%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.31%
H: 0.02%
C: -1.05%
cancer diagnostics diagnostic
Anticoagulant Reversal Drugs Market Size Is Projected to Reach $2.20 Billion By 2028 | CAGR: 14.4%: Polaris Market Research
Published: 2021-09-07 (Crawled : 13:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.23%
H: 1.09%
C: -0.51%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: -0.72%
H: 1.0%
C: 0.45%
drug research
Rise in Prevalence of Blood-related Disorders, Number of Cardiovascular Surgeries Creates Growth Opportunities in Fibrin Sealants Market, Notes TMR
Published: 2021-09-06 (Crawled : 11:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
| Email alert
Add to watchlist
GRFS | News | $6.29 -3.82% -3.97% 1.2M
|
Health Technology
| Email alert
Add to watchlist
blood cardiovascular growth cardio
Global Clinical Nutrition Market (2021 to 2029) - Featuring Danone, GlaxoSmithKline and Hospira Among Others
Published: 2021-09-03 (Crawled : 14:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
PRGO | News | $30.8 2.87% -1.14% 1.2M
|
Health Technology
|
| O: 0.19%
H: 1.39%
C: 0.87%
ERIC | News | $5.1 0.79% 0.78% 19M
|
Electronic Technology
|
| O: -0.66%
H: 0.33%
C: 0.33%
nutrition
Pfizer Announces Start of Phase 3 Clinical Trial in Adults for Its Investigational Vaccine Against Respiratory Syncytial Virus (RSV)
Published: 2021-09-02 (Crawled : 12:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.96%
H: 0.84%
C: 0.77%
respiratory vaccine phase 3 trial
Valneva to Participate in Goldman Sachs Eleventh Annual Biotech Symposium
Published: 2021-09-01 (Crawled : 17:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.26%
H: 0.15%
C: -0.32%
biotech iot symposium
Global Industry Analysts Predicts the World Human Reproductive Technologies Market to Reach $28 Billion by 2026
Published: 2021-09-01 (Crawled : 14:15) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.26%
H: 0.15%
C: -0.32%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.13%
H: 0.49%
C: 0.49%
Positive Top-Line Results From Pfizer’s Phase 3 JADE DARE Trial Comparing the Efficacy of Abrocitinib and Dupilumab for Moderate to Severe Atopic Dermatitis
Published: 2021-08-30 (Crawled : 11:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -2.47%
H: 2.08%
C: 1.21%
positive results dermatitis phase 3 trial topline atopic dermatitis
Pfizer Announces New Chief Business Innovation Officer
Published: 2021-08-26 (Crawled : 13:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.4%
H: 0.96%
C: -0.67%
Pfizer and BioNTech Announce Collaboration with Brazil’s Eurofarma to Manufacture COVID-19 Vaccine Doses for Latin America
Published: 2021-08-26 (Crawled : 11:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.4%
H: 0.96%
C: -0.67%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.37%
H: 0.19%
C: -0.25%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -1.34%
H: 1.78%
C: -0.27%
covid brazil collaboration vaccine announces collaboration
Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of COMIRNATY® in Individuals 16 and Older
Published: 2021-08-25 (Crawled : 17:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.7%
H: 0.5%
C: -1.1%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.71%
H: 0.37%
C: 0.08%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -2.02%
H: 4.37%
C: 4.23%
fda license submission comirnaty® order
Applied Molecular Transport Appoints Holly Schachner, M.D. to its Board of Directors
Published: 2021-08-24 (Crawled : 22:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.38%
H: 0.62%
C: -2.73%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.69%
H: 0.42%
C: 0.1%
AMTI 4 | $0.263 -14.3% -1.14% 0
|
Health Technology
|
| O: -0.23%
H: 0.3%
C: -0.84%
molecular
Novan Appoints Tomoko Maeda-Chubachi, MD, PhD, MBA as Chief Medical Officer
Published: 2021-08-24 (Crawled : 13:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.38%
H: 0.62%
C: -2.73%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.6%
H: 0.47%
C: -1.29%
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 2.16%
H: 2.65%
C: 2.12%
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older
Published: 2021-08-23 (Crawled : 16:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 3.22%
H: 2.13%
C: -0.72%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.28%
H: 0.09%
C: -0.59%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 7.12%
H: 3.88%
C: 2.3%
covid fda fda approval vaccine approval comirnaty® order
Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026
Published: 2021-08-20 (Crawled : 15:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.37%
H: 1.53%
C: -0.53%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.56%
H: 0.87%
C: 0.7%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.17%
H: 0.67%
C: 0.26%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.24%
H: 0.46%
C: 0.1%
Global Active Pharmaceutical Ingredients/API Market to Reach $274.8 Billion by 2026
Published: 2021-08-17 (Crawled : 16:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.27%
H: 3.51%
C: 3.36%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.19%
H: 0.86%
C: 0.79%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.45%
H: 1.74%
C: 0.57%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.0%
H: 0.7%
C: 0.41%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.29%
H: 1.11%
C: 1.06%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.42%
H: 1.58%
C: 1.44%
Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine
Published: 2021-08-16 (Crawled : 16:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 1.54%
H: 1.53%
C: 1.41%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.17%
H: 0.62%
C: 0.48%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -2.42%
H: 0.45%
C: -6.81%
covid fda vaccine submission
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.